SCHEMBL3500556

SCHEMBL3500556

CCCCOC(=O)COC(=O)c1ccccc1C(=O)OCCCC

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.81
TDP1 Q9NUW8 3/20 0.81
L3MBTL1 Q9Y468 2/20 0.81
CYP3A4 P08684 3/20 0.73
MAPK1 P28482 3/20 0.73
TP53 P04637 1/20 0.73
ALDH1A1 P00352 7/20 0.71
LMNA P02545 2/20 0.71
HSD17B10 Q99714 2/20 0.65
KDM4E B2RXH2 2/20 0.57
POLB P06746 1/20 0.57
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CA2 P00918 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ESR1 P03372 1/20 0.49
CYP2D6 P10635 1/20 0.49
NR1H2 P55055 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28229224 0.98 TSHR (0.77) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL2330224 0.90 TSHR (1.00) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL29353340 0.90 TSHR (1.00) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL24051 0.90 TSHR (1.00) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL4596231 0.90 TSHR (1.00) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL9771936 0.89 TSHR (0.83) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL23248522 0.88 TSHR (0.96) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL9747706 0.88 TSHR (0.96) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL11287116 0.88 TSHR (0.96) TSHRTDP1L3MBTL1CYP3A4MAPK1
Dibutyl Phthalate SCHEMBL2330218 0.88 TSHR (0.96) TSHRTDP1L3MBTL1CYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595361-B2 Transferable composition and methods for preparing and using the same LUMET TECHNOLOGIES LTD. (IL) 2026-04-07 US disclosed
US-20250134883-A1 NOVEL COMPOSITIONS ARTISAN THERAPEUTICS, INC. 2025-05-01 US disclosed
EP-4469031-A1 LIQUID RESIN EXTENDED-RELEASE ORAL NALTREXONE FORMULATION FOR TREATING AUTISM-RELATED DISORDERS Aardvark Therapeutics Inc. (US) 2024-12-04 EP disclosed
EP-4469027-A2 NOVEL COMPOSITIONS Tulex Pharmaceuticals Inc. (US) 2024-12-04 EP disclosed
US-20240366505-A1 Liquid Resin Extended-Release Oral Naltrexone Formulation for Treating Autism-Related Disorders Aardvark Therapeutics, Inc. (US) 2024-11-07 US disclosed
EP-4384571-A1 REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTER BASED NEGATIVE BIREFRINGENT COMPENSATION FILMS HAVING IMPROVED WAVELENGTH DISPERSION Eastman Chemical Company (US) 2024-06-19 EP disclosed
EP-3355707-B1 HIGHLY HOMOGENOUS HYDROPHILIC GUM BASES WRIGLEY W M JUN CO (US) 2024-05-08 EP disclosed
CN-116981742-A Antifouling coating composition 日东化成株式会社 2023-10-31 CN disclosed
US-20230343604-A1 SEMICONDUCTOR DEVICE AND METHOD TAIWAN SEMICONDUCTOR MFG CO LTD (TW) 2023-10-26 US disclosed
US-20230343604-A1 SEMICONDUCTOR DEVICE AND METHOD TAIWAN SEMICONDUCTOR MFG CO LTD (TW) 2023-10-26 US disclosed
US-6738251-B2 METAL POWDER CONTAINING NOT LESS THAN 95 MASS % OF AG, A SINTERING RESTRAINER CONTAINING CR AND/OR CR COMPOUND, A DIELECTRIC LOSS CONDITIONER CONTAINING MN AND/OR MN COMPOUND, AND A VEHICLE TDK CORPORATION (JP) 2004-05-18 US disclosed
US-20020187317-A1 Conductive Pattern Incorporated in a Multilayered Substance, Multilayered Substance Incorporating a Conductive Pattern, and a Method of Fabricating a Multilayered Substrate TDK CORPORATION (JP) 2002-12-12 US disclosed
CN-1382741-A Cellulose ester membrane KONISHIROKU PHOTO IND (JP) 2002-12-04 CN disclosed
EP-1184882-A1 CONDUCTOR PATTERN BUILT IN MULTILAYER BOARD, MULTILAYER BOARD HAVING BUILT-IN CONDUCTOR PATTERN, AND METHOD OF MANUFACTURING MULTILAYER BOARD TDK Corporation (JP) 2002-03-06 EP disclosed
US-6284036-B1 PIGMENTING POROUS SINTERED MATERIAL COMPRISING BORIDE, CARBIDE, SILICIDE, NITRIDE OR PHOSPHIDES BY APPLYING SOLUTION OF SOLUBLE PIGMENT DERIVATIVE AND REGENERATING ORGANIC PIGMENT BY HEATING TO DEPOSIT PIGMENT IN PORES CIBA SPECIALTY CHEMICALS CORPORATION 2001-09-04 US disclosed
EP-1044945-A1 Heat stable, pigmented sintered material comprising a boride, carbide, silicide, nitride or phosphide Ciba SC Holding AG (CH) 2000-10-18 EP disclosed
US-5843524-A Vinyl halide polymer color concentrate FERRO CORPORATION (US) 1998-12-01 US disclosed
EP-0684876-A4 VINYL HALIDE POLYMER COLOR CONCENTRATE. FERRO CORP (US) 1996-06-05 EP disclosed
EP-0684876-A1 VINYL HALIDE POLYMER COLOR CONCENTRATE FERRO CORPORATION (US) 1995-12-06 EP disclosed
WO-1995017265-A1 VINYL HALIDE POLYMER COLOR CONCENTRATE FERRO CORPORATION (US) 1995-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595361-B2 Transferable composition and methods for preparing and using the same PIEZO1, DSG1, PIGT TSHR 3730/4885TDP1 1310/4885L3MBTL1 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.